If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosebank Regulatory News (ROSE)

Share Price Information for Rosebank (ROSE)

Share Price is delayed by 15 minutes
Get Live Data
324.00    -11.00 (-3.28%)
Bid:
326.00
Ask:
328.00
Spread: 2.00 (0.613%)
Market Cap: £3.20b
ROSE Live PriceLast checked at - London Stock Exchange

Intraday Rosebank Share Chart

Director/PDMR Shareholding

4 Oct 2011 14:30

RNS Number : 5329P
Vane Minerals PLC
04 October 2011
Β 

ο»Ώ

VANE Minerals Plc

("VANE" or the "Company")

Director Dealings

The Directors of VANE were notified on 4 October 2011 that on 4 October Mr Matthew Idiens has purchased 500,000 of the Company's ordinary shares ("Ordinary Shares") at an average price of 0.84p each. Following this transaction, Mr Idiens has an indirect beneficial interest in 14,805,880 shares representing 4.53% of the Company's issued share capital.

As at the date of this announcement, the Company's issued share capital consists of 326,923,658 Ordinary Shares. The Company does not hold any Ordinary Shares in Treasury.

On 29 September 2011, the Company announced that it was issuing a further 116,000,000 new Ordinary Shares pursuant to a placing, conditional on shareholder approval and admission of these new Ordinary Shares to trading on AIM ("Admission"). On Admission, the Company's issued share capital will consist of 442,923,658 Ordinary Shares and Mr Idiens shareholding will represent 3.34% of the Company's issued share capital as enlarged by the Placing.

For further information, please contact:

VANE Minerals plc

David Newton, CEO +44 (0) 20 7225 4590

Allenby Capital

Brian Stockbridge/Alex Price +44 (0) 203 328 5656

Threadneedle Communications

Laurence Read/ Beth Harris +44 (0) 20 7653 9850

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSFSLFDLFFSEFS
Date   Source Headline
5th May 20204:20 pmRNSHolding(s) in Company
1st May 20207:00 amRNSOperations and Strategy Update
10th Feb 20207:00 amRNSUpdate on restructuring of the Paradox project
10th Feb 20207:00 amRNSUpdate on McCoy Lease Working Interest Acquisition
31st Dec 20191:00 pmRNSTotal Voting Rights
3rd Dec 201912:27 pmRNSIssue of Equity and change to TVR
29th Nov 20195:00 pmRNSTotal Voting Rights
22nd Nov 20194:52 pmRNSHolding(s) in Company
21st Nov 201912:43 pmRNSResult of General Meeting and change to TVR
14th Nov 20192:10 pmRNSHolding(s) in Company
8th Nov 20194:12 pmRNSHolding(s) in Company
4th Nov 20192:16 pmRNSDirector/PDMR shareholding
4th Nov 20197:05 amRNSIssue of equity and notice of general meeting
4th Nov 20197:00 amRNSProposed Acquisition-McCoy Interest & Fundraising
14th Oct 20197:00 amRNSRestructuring of the Paradox project
30th Sep 20197:00 amRNSHalf-year Report
3rd Sep 20197:00 amRNSDirectorate Changes and Board Restructuring
2nd Sep 201910:59 amRNSHolding(s) in Company
30th Aug 20195:00 pmRNSTotal Voting Rights
22nd Aug 20197:00 amRNSIssue of equity and change to total voting rights
30th Jul 201912:46 pmRNSResult of AGM and update on Board composition
10th Jul 20193:01 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSBoard appointment and update
28th Jun 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSNotice of Annual Results
3rd Jun 20197:00 amRNSTotal Voting Rights
24th May 20197:00 amRNSSubscription completion, board appointment & TVR
20th May 20197:00 amRNSIssue of equity and Board Changes
30th Apr 20197:00 amRNSUpdated Corporate Presentation
23rd Apr 20197:00 amRNSDirectorate Change
12th Apr 20193:40 pmRNSHolding(s) in Company
12th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSIssue of equity and Board Changes
28th Mar 20197:00 amRNSUpdate & Proposed Board Changes
26th Mar 20199:41 amRNSHolding in Company - Correction
12th Mar 20194:17 pmRNSHolding(s) in Company
5th Mar 20196:09 pmRNSHolding(s) in Company
5th Mar 20199:12 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSAcquisition of additional acreage in Paradox Basin
7th Jan 20197:00 amRNSSchlumberger Study Results
6th Dec 20187:00 amRNSOperations Update
27th Nov 20187:00 amRNSDatabase Agreement & North Wash Vanadium update
1st Nov 20187:00 amRNSBLM Approval for Permit to Drill GV 22-1 well
3rd Oct 20187:00 amRNSHolding(s) in Company
25th Sep 20187:00 amRNSHalf-year Report
18th Jul 20181:46 pmRNSHolding(s) in Company
18th Jul 20181:44 pmRNSHolding(s) in Company
3rd Jul 20181:47 pmRNSCantor Fitzgerald initiates research coverage
28th Jun 201811:28 amRNSResult of AGM
28th Jun 20187:00 amRNSInterviews with CEO Matthew Idiens

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.